Profil
Dr. Hella Kohlhof is a Chief Scientific Officer at Immunic, Inc. Dr. Kohlhof was previously employed as a Chief Science Officer by Vital Therapies, Inc., a Director-Projects Development by 4SC AG, and a Managing Director by Immunic Research GmbH.
She received her doctorate degree from Ludwig-Maximilians-Universität München.
Postes actifs de Hella Kohlhof
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNIC, INC. | Directeur Technique/Scientifique/R&D | 01/01/2017 |
Anciens postes connus de Hella Kohlhof
| Sociétés | Poste | Fin |
|---|---|---|
Immunic Research GmbH | Directeur Général | - |
| 4SC AG | Corporate Officer/Principal | - |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Directeur Technique/Scientifique/R&D | - |
Formation de Hella Kohlhof
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
4SC AG
4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotherapeutic company focused on developing a cell-based therapy | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Immunic Research GmbH |
















